Bright Uro, Inc. Secures $15 Million in Equity Fundraise via SEC Form D Filing

Bright Uro, Inc., a biotechnology company based in Irvine, CA, has successfully completed a $15 million equity fundraising round as reported in their recent SEC Form D filing dated September 5, 2025. The offering, which was sold to 35 investors, utilized federal exemption 06b.